Skip to main content
. 2016 Feb 9;7:113. doi: 10.3389/fmicb.2016.00113

Table 2.

Determination of minimum inhibitory concentration of fractions and pure compounds obtained from secondary metabolites produced by Pseudomonas aeruginosa LV strain, against Xcc 306.

Sample MIC (μg mL-1)
DP 78.12
F3 19.53
F3d 6.25
F3d.3.4.2 (OAC) 0.12
NC

Negative control (NC); dichloromethane phase (DP); no antibiotic activity (–); organocopper antibiotic compound (OAC).